Patent and Trademark Office October 11, 2019 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Grant of Interim Extension of the Term of U.S. Patent No. 6,406,699-ECI® (ELIAS Cancer Immunotherapy)
The United States Patent and Trademark Office has issued an order granting interim extension for a one-year interim extension of the term of U.S. Patent No. 6,406,699.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.